PLoS ONE · 2013 · 41 citations · 27 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionEsophageal CancerMalignant NeoplasmsMetastatic CascadeMolecular Tumor ProfilingCancer Metastasis MechanismsEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersImmunohistochemical MarkersImmunohistochemical StainingMalignant ProgressionPrognostic BiomarkersTumor Metastasis Biology
Gastroesophageal junction (GEJ) adenocarcinoma carries a poor prognosis that is largely attributable to early and frequent metastasis. The acquisition of metastatic potential in cancer involves epithelial-to-mesenchymal transition (EMT). The metastasis-associated gene MTA3, a novel component of the Mi-2/NuRD transcriptional repression complex, was identified as master regulator of EMT through inhibition of Snail to increase E-cadherin expression in breast cancer. Here, we evaluated the expression pattern of the components of MTA3 pathway and the corresponding prognostic significance in GEJ adenocarcinoma. MTA3 expression was decreased at both protein and mRNA levels in tumor tissues compared to the non-tumorous and lowed MTA3 levels were noted in tumor cell lines with stronger metastatic potential. Immunohistochemical analysis of a cohort of 128 cases exhibited that patients with lower expression of MTA3 had poorer outcomes. Combined misexpression of MTA3, Snail and E-cadherin had stronger correlation with malignant properties. Collectively, results suggest that the MTA3-regulated EMT pathway is altered to favor EMT and, therefore, disease progression and that MTA3 expression was an independent prognostic factor in patients with GEJ adenocarcinoma.
27
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.5K citations
Medicine, Oncology, Pharmacology +15
MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer
Naoyuki Fujita, David L. Jaye, Masahiro Kajita et al. · Cell · 2003 · 509 citations · Full text
TNM seventh edition: What's new, what's changed
Leslie H. Sobin, Carolyn C. Compton · Cancer · 2010 · 473 citations · Full text
MTA3 and the Mi-2/NuRD Complex Regulate Cell Fate during B Lymphocyte Differentiation
Naoyuki Fujita, David L. Jaye, Cissy Geigerman et al. · Cell · 2004 · 323 citations · Full text